First-Trimester Ultrasound Screening Study
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This study evaluates ultrasound screening for pregnant women between 11 and 14 weeks of pregnancy. Researchers are testing a method called AutoFUSE to help identify pregnancies that may need closer monitoring or additional care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant with one baby (not twins or multiples)
- Your pregnancy is between 11 weeks and 13 weeks plus 6 days along
- Your baby has a heartbeat (confirmed as a live pregnancy)
- You are scheduled for or willing to have a first-trimester ultrasound scan
- Your pregnancy has not had unexplained miscarriage or fetal loss
- You do not have serious pregnancy complications (such as preeclampsia, gestational diabetes, or placental problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound system designed specifically for pregnancy imaging. Researchers want to make sure it works well and safely captures clear images of your baby during mid-pregnancy (weeks 18–28).
This study uses ultrasound to look for birth defects in babies during the second and third trimesters of pregnancy. It may help understand how well ultrasound can detect problems in healthy pregnancies.
This study uses ultrasound to examine fetal brain and spine development in pregnant women. It compares scans from pregnancies where a brain or spine issue is suspected with those from healthy pregnancies to improve understanding and diagnosis.
This study asks pregnant people with a normal ultrasound to join research where fetal tissue may be collected at an important point in pregnancy (7–20 weeks). It aims to better understand fetal development, and participation requires being able to understand the study in English.
This study offers a combined screening test for pregnant women in their first trimester. It helps check for potential health issues early in pregnancy.
This study uses advanced genetic testing (whole genome sequencing) on tissue samples from fetuses with structural abnormalities detected on ultrasound. The goal is to identify genetic causes of birth defects to help with diagnosis and understanding of your baby's condition.
Hear when a new Fetus Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.